|
End-of-day quote
New Zealand S.E.
19/08/2026
|
5-day change | 1st Jan Change | ||
| 4.390 NZD | +3.29% |
|
-2.88% | +29.88% |
| 07-31 | AFT Pharmaceuticals Limited - Shareholder/Analyst Call | |
| 07-31 | New Zealand Shares Fall; AFT Pharmaceuticals Chair to Retire | MT |
| Market Cap | 460M 273M 234M 219M 200M 377M 26.08B 383M 2.58B 1.01B 13.08B 1.02B 1B 43.24B | P/E 2027 * |
23.4x | P/E 2028 * | 18.6x |
|---|---|---|---|---|---|
| Enterprise Value | 490M 290M 249M 233M 213M 401M 27.77B 408M 2.75B 1.08B 13.93B 1.09B 1.07B 46.04B | EV / Sales 2027 * |
1.61x | EV / Sales 2028 * | 1.4x |
| Free-Float |
22.37% | Yield 2027 * |
0.75% | Yield 2028 * | 0.95% |
Last Transcript: AFT Pharmaceuticals Limited
| 20/01/24 | Rentevrees zet Bel20 onder druk | |
| 19/01/24 | KBC uitblinker op groene beurs | |
| 19/01/24 | Brusselse beurs opent flink hoger | |
| 19/01/24 | Brussel start handelsdag vermoedelijk in het groen | |
| 19/01/24 | Hyloris gaat samenwerken met AFT Pharmaceuticals |
| 1 day | +3.29% | ||
| 1 week | -2.88% | ||
| Current month | -8.73% | ||
| 1 month | +12.28% | ||
| 3 months | +27.25% | ||
| 6 months | +18.33% | ||
| Current year | +29.88% |
| 1 week | 4.23 |  | 4.45 |
| 1 month | 3.94 | | 4.85 |
| Current year | 3.35 | | 4.85 |
| 1 year | 2.56 | | 4.85 |
| 3 years | 2.37 | | 4.85 |
| 5 years | 2.37 | | 5 |
| 10 years | 1.7 | | 5.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marree Atkinson
HRO | Human Resources Officer | - | 04/09/2012 |
Hartley Atkinson
CEO | Chief Executive Officer | - | 04/09/1997 |
Stuart Houliston
DFI | Director of Finance/CFO | - | 15/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Theodore Witek
BRD | Director/Board Member | 69 | 23/12/2020 |
David Flacks
CHM | Chairman | - | 22/06/2015 |
Hartley Atkinson
BRD | Director/Board Member | - | 04/09/1997 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/7/25 | Buy | Founder | 200,000 | 0.1907% | ||
| 26/6/25 | Free | Founder | 17,755 | 0.0169% | ||
| 2/12/24 | Buy | Founder | 45 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.29% | -2.88% | +68.85% | +27.25% | 273M | |
| +4.46% | +4.92% | +82.07% | +134.31% | 1,141B | |
| +0.85% | +4.81% | +53.77% | +58.51% | 659B | |
| +2.72% | +6.92% | +28.99% | +77.15% | 470B | |
| +1.80% | +0.52% | +41.20% | +44.05% | 366B | |
| +1.24% | +2.35% | +25.99% | +42.21% | 302B | |
| +2.07% | +2.97% | +2.27% | +13.06% | 254B | |
| +4.02% | +6.29% | +49.67% | +68.96% | 239B | |
| +1.05% | -0.02% | -13.96% | -52.13% | 207B | |
| +2.90% | +8.63% | +25.11% | +94.52% | 183B | |
| Average | +2.06% | +3.60% | +36.40% | +50.79% | 382.12B | |
| Weighted average by Cap. | +1.53% | +4.31% | +47.06% | +74.14% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304M 180M 154M 144M 132M 249M 17.21B 253M 1.7B 666M 8.63B 676M 661M 28.53B | 345M 205M 175M 164M 150M 283M 19.55B 287M 1.93B 757M 9.81B 768M 751M 32.43B |
| Net income | 19.7M 11.67M 10.01M 9.35M 8.58M 16.13M 1.12B 16.39M 110M 43.19M 559M 43.82M 42.87M 1.85B | 24.81M 14.7M 12.61M 11.78M 10.81M 20.32M 1.41B 20.65M 139M 54.42M 705M 55.21M 54.01M 2.33B |
| Net Debt | 29.84M 17.68M 15.17M 14.16M 12.99M 24.43M 1.69B 24.83M 167M 65.43M 847M 66.38M 64.94M 2.8B | 24.6M 14.58M 12.5M 11.67M 10.71M 20.14M 1.39B 20.47M 138M 53.94M 699M 54.73M 53.54M 2.31B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/08/26 | NZ$4.390 | +3.29% | 139,745 |
| 18/08/26 | NZ$4.250 | -1.16% | 27,527 |
| 17/08/26 | NZ$4.300 | -2.27% | 8,824 |
| 14/08/26 | NZ$4.400 | -0.68% | 21,830 |
| 13/08/26 | NZ$4.430 | -1.99% | 3,377 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AFT Stock
Select your edition
All financial news and data tailored to specific country editions
